The announcement noted that these drugs accounted for about one-fifth of total Part D–covered prescription drug costs between June 1, 2022, and May 31, 2023, or approximately $50.5 billion.

Currently, there‘s no universal Medicare drug price list available, as drug costs and availability vary according to the private insurer administering the Part D prescription drug plan. Contact ...

GoodRx reports that insurance formularies are shrinking, leading to fewer covered medications and increased restrictions on ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The White House Aug. 13 released an executive order directing the Department of Health and Human Services’ Office of the ...

If you need a drug that isn't on your health plan's list, your doctor can submit a formulary exception request for you. You might need to do this for several reasons, Norris says.

Now, Ozempic and others in the “GLP-1” category of drugs are approaching that critical mass. They are showing promise for an ever-expanding list of diseases, beyond today’s most common uses ...

Drugs a plan must cover Every Part D plan must cover all medications in “protected” drug classes. (A class or category is a group of drugs that have similar effects on the body or treat the ...

Under the Medicare Prescription Drug Inflation Rebate Program, some beneficiaries that use one or more of the 41 rebatable drugs on the list may save between $1 and $3,575 per average dose ...